Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Non-Small Cell Lung Cancer Therapy - Study findings on non-small cell lung cancer therapy are outlined in reports from R. Blanco and colleagues
Pharmacokinetics - Research data from S. Rohatagi and colleagues update understanding of pharmacokinetics
Acusphere, Inc. - Acusphere Announces Data Demonstrating Imagify Perfusion Stress Echo Predicts Presence of Coronary Artery Disease
Adverse Drug Reactions - Aegerion Pharmaceuticals, Inc. Announces AEGR-733 Phase II Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Hepatic Safety Profile Preliminary Phase III Data Also Shows Signs of Efficacy, Safety and
Affymax, Inc. - Affymax Announces New Data Presented on the Long-Term Safety and Effectiveness of Hematide to Treat Anemia in Chronic Renal Failure Patients with Monthly Dosing
Affymetrix, Inc. - Affymetrix Announces New Cost-effective Product for Standardizing Drug Metabolism Studies
Alzheimer Disease - Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease
Alzheimer Disease - RVX-208 Exploratory Study Illustrates Early Potential for Alzheimer's Disease
Bioscience - Alexander R. Giaquinto, Ph.D., Joins Regado Biosciences as Senior Vice President of Regulatory Affairs and Quality Assurance
Breast Cancer - Karmanos Cancer Institute Seeks Breast Cancer Patients to Participate in a New Drug Trial
Celiac Disease - Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
Enzyme Research - Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
Gene Therapy - Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
Heart Attack - Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data
Heart Failure - Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera's Relaxin in Acute Heart Failure
Helion Biotech - Helion Biotech Receives Funding from SEED Capital Denmark to Progress MASP-2 Protein Replacement for Cancer-Supportive Care
HIV/AIDS - GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
Hormones - Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated
ImClone Systems Incorporated - Phase 2 Study of IMC-1121B in First-Line Treatment of Advanced Non-Small Cell Lung Cancer Commences Patient Enrollment
LifeCycle Pharma A/S - LCP-AtorFen Phase II Data to Be Presented at the American Heart Association's 2008 Scientific Sessions in New Orleans, LA, on November 11
Myeloma - Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
Oncothyreon Inc. - Oncothyreon reports third quarter 2008 financial results
Optimer Pharmaceuticals, Inc. - Optimer Pharmaceuticals Reports Positive Data from its North American Phase 3 CDI Study of OPT-80
Sepracor - Results of Studies of ALVESCO for the Treatment of Asthma and OMNARIS in an HFA Nasal Aerosol Presented at American College of Allergy, Asthma & Immunology Annual Meeting
Stem Cell Research - Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
Surgery - Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
Tercica, Inc. - Tercica Announces Results from Increlex Phase IIIb Study Demonstrating Dose-Dependent Height Velocity Increase in Primary IGFD Short Stature Population and Other Increlex Studies at the 13th International Congress of Endocrinology Meeting
Tinnitus - Merz Pharmaceuticals tinnitus candidate enters into Phase III
Urea Cycle Disorders - Hyperion Therapeutics Completes Phase 2 Data Analysis and Schedules End of Phase 2 Meeting With FDA for HPN-100 in the Chronic Treatment of Urea Cycle Disorders
Urinary Tract Infection - Novexel's NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections
